» Articles » PMID: 36741604

Beyond the Local Basic Panel: Full CFTR Gene Analysis Identifies Novel CF Mutation Missed on Standard Testing in an Arabic Child

Overview
Journal Cureus
Date 2023 Feb 6
PMID 36741604
Authors
Affiliations
Soon will be listed here.
Abstract

Cystic fibrosis (CF) is an autosomal recessive disease caused by different mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. It is the most common inherited disorder in the Caucasian population, with around 2000 mutations identified for the CFTR gene. The precise prevalence of CF in Arab countries remains unknown, with the prevalence of F508 del found to be a common type with other endemic mutations. We describe the case of a CF patient who was diagnosed at the age of seven years. She presented post-cardiac surgery for further evaluation for a recurrent chest infection and subtle dysmorphic features. CF genetic testing for the most common 31 mutations (CF panel) was negative, and a novel mutation was identified on CFTR gene sequencing.

Citing Articles

A Unique Mutation in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene Causing Cystic Fibrosis in a Pakistani Child: A Case Highlighting the Need for More Awareness.

Yavuz S, Elnazir B, Amin S, Sherif A, Saif S, Francis N Cureus. 2024; 16(2):e54627.

PMID: 38524055 PMC: 10959411. DOI: 10.7759/cureus.54627.


Comparison of refugee patients with cystic fibrosis and their counterpart children from Turkey during the war.

Yilmaz A, Pekcan S, Sismanlar Eyuboglu T, Hangul M, Arslan H, Ayzit Kilinc A Eur J Pediatr. 2024; 183(4):1831-1838.

PMID: 38265526 PMC: 11001702. DOI: 10.1007/s00431-024-05431-8.

References
1.
Highsmith W, Burch L, Zhou Z, Olsen J, Boat T, Spock A . A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations. N Engl J Med. 1994; 331(15):974-80. DOI: 10.1056/NEJM199410133311503. View

2.
Bobadilla J, Macek Jr M, Fine J, Farrell P . Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening. Hum Mutat. 2002; 19(6):575-606. DOI: 10.1002/humu.10041. View

3.
Gallati S . Disease-modifying genes and monogenic disorders: experience in cystic fibrosis. Appl Clin Genet. 2014; 7:133-46. PMC: 4104546. DOI: 10.2147/TACG.S18675. View

4.
Banjar H, Angyalosi G . The road for survival improvement of cystic fibrosis patients in Arab countries. Int J Pediatr Adolesc Med. 2019; 2(2):47-58. PMC: 6372404. DOI: 10.1016/j.ijpam.2015.05.006. View

5.
Pallin M . Cystic fibrosis vigilance in Arab countries: The role of genetic epidemiology. Respirology. 2018; 24(2):93-94. DOI: 10.1111/resp.13461. View